Charlottesville, VA · Founded 2013 · Privately Held (backing)
Developer of a peptide therapy designed for the treatment of signs and symptoms of dry eye in primary sjögren's syndrome patients. TearSolutions is based in Charlottesville, VA and was founded in 2013. Its last reported valuation was $280 million in Nov 2024. It has raised $44.1 million across 11 recorded rounds; the latest was a $517,000 seed round in Oct 2025.
Last reported valuation
$280.0M
Oct 2026
Priced at
—
Total raised
$44.1M
Last round
Seed Round
Oct 2025
No prints on record
No secondary trades in TearSolutions shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of TearSolutions with a free account
·The complete investor list: 13 names
·Watch TearSolutions: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of TearSolutions stock.
